Search

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse...

https://www.nytimes.com/2022/07/17/health/cancer-overtesting.html

BOSTON – Beth Israel Deaconess Medical Center (BIDMC) has been named by U.S. News & World Report a 2025-2026 Best Hospital. BIDMC was ranked among the top 50 hospitals nationwide in nine adult specialties and was ranked in the top 25 hospitals in five of those specialties. The hospital also received...

The Pathogens, Immunity and Inflammation Hub is pleased to bring back the “ On the Cross-Road of Immunology and Women’s Health Seminar Series” this fall and throughout the academic year! This series will feature talks and panel discussions by BIDMC experts about: Immunologic conditions more common...

The Neuroscience Connections Hub hosts Directors of the BIDMC Research Core Facilities the first Monday of every month to present about the capabilities in their Research Core On November 4 th from 12-1 pm in CLS 621, Dr. Jennifer Stevens, the Director of the Center for Healthcare Delivery Science...

The Immunology Think Tank hosted Dr. Hiroshi Takayanagi, who gave a presentation about “Osteoclasts, Osteoimmunology and Autoimmunity” on April 22nd 2025 from 4:00 – 5:00 pm, in the CLS 921 Conference Room

The Pathogens, Immunity and Inflammation Translational Research Hub has been hosting a new three-part course titled How to Win Industry Funding: Industry-Sponsored Research Funding 101. The first part of this course, Introduction to Industry-Sponsored Research Funding was held June 22, 2023, and the...

The Interventional Cardiology and Vascular Research Section was well-represented at this year's AHA conference, which took place in New Orleans. Mentees Dr. Joe Kim, Dr. Nathan Watson, and Dr. Herzig gave fantastic presentations on the topics of pulmonary embolism therapies, antiphospholipid...